1. |
Detterbeck FC, Boff DJ, Kim AW, et al. The eighth edition lung cancer stage classification. Chest, 2017, 151: 193-203.
|
2. |
Chen KN. The diagnosis and treatment of lung cancer presented as ground-glass nodule. Gen Thorac Cardiovasc Surg, 2020, 68(7): 697-702.
|
3. |
Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol, 2011, 6(2): 244-285.
|
4. |
Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol, 2015, 10(9): 1243-1260.
|
5. |
Chen KN. Commentary: Exquisite surgical techniques and comprehensive oncological theory are two fundamental requirement of learning lung cancer surgery. JTCVS technique, 2021: Accepted.
|
6. |
Suzuki K, Koike T, Asakawa T, et al. Japan Lung Cancer Surgical Study Group (JCOG LCSSG). A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical ⅠA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol, 2011, 6(4): 751-756.
|
7. |
Ito H, Suzuki K, Mizutani T, et al. Long-term survival outcome after lobectomy in patients with clinical T1 N0 lung cancer. J Thorac Cardiovasc Surg, 2020: S0022-5223(20)30054-4.
|
8. |
Hattori A, Matsunaga T, Takamochi K, et al. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer. J Thorac Cardiovasc Surg, 2017, 154(6): 2102-2110.
|
9. |
Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg, 1995, 60(3): 615-622.
|
10. |
Suzuki K, Watanabe SI, Wakabayashi M, et al. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer. J Thorac Cardiovasc Surg, 2020: S0022-5223(20)33043-9.
|
11. |
Miyoshi T, Aokage K, Wakabayashi M, et al. Prospective evaluation of watchful waiting for early-stage lung cancer with ground-glass opacity: A single-arm confirmatory multicenter study: Japan Clinical Oncology Group study JCOG1906 (EVERGREEN study). Jpn J Clin Oncol. 2021, hyab074. doi: 10.1093/jjco/hyab074.
|
12. |
Asamura H, Okada M, Saji H, et al. Randomized trial of segmentectomy compared to lobectomy in small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). 101st AATS conference. Oral presentation.
|
13. |
Shimoyama R, Tsutani Y, Wakabayashi M, et al. A multi-institutional randomized phase Ⅲ trial comparing anatomical segmentectomy and wedge resection for clinical stage ⅠA non-small cell lung cancer in high-risk operable patients: Japan Clinical Oncology Group Study JCOG1909 (ANSWER study). Jpn J Clin Oncol, 2020, 50(10): 1209-1213.
|
14. |
Chae YK, Oh MS. Detection of minimal residual disease using ctDNA in lung cancer: Current evidence and future directions. J Thorac Oncol, 2019, 14(1): 16-24.
|
15. |
Newman AM, Bratman SV, To J, et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med, 2014, 20(5): 548-554.
|